1/25
Vocabulary flashcards covering ventilation-perfusion ratios, pulmonary function measurements, asthma pathophysiology and pharmacology, and chronic obstructive pulmonary disease (COPD).
Hypercapnia
The presence of excess CO2 in the arterial blood.
Hypoxemia
Abnormally low O2 content in the blood.
Ventilation-Perfusion (V/Q) Ratio
A clinical ratio used to assess the efficiency and adequacy of ventilation (V) and perfusion (Q).
Normal V/Q
The physiological state in which equal amounts of air and blood enter the respiratory portion of the lungs.
Low V/Q (Shunt)
A ventilation-perfusion mismatch characterized by decreased ventilation despite normal perfusion (e.g., seen in asthma or lung injury), carrying a risk of respiratory acidosis.
High V/Q (Dead Space)
A ventilation-perfusion mismatch characterized by normal or high ventilation paired with decreased or impaired perfusion at the alveolar sacs (e.g., seen in pulmonary embolism).
Forced Expiratory Volume in 1 second (FEV1)
A spirometry parameter measuring the volume of air forcefully exhaled during the first second after a full inhalation; values of 75%+ (approximately 4L) are considered normal.
Forced Vital Capacity (FVC)
The total volume of air exhaled quickly and forcefully following a complete inhalation, typically measuring around 5L over 4 to 6 seconds.
Asthma
A chronic inflammatory airway disease characterized by bronchial hyperresponsiveness, bronchospasm, thick mucus production, and long-term scar tissue formation.
Bronchial Hyperresponsiveness
An abnormal closure and narrowing of the small airways leading to symptoms such as wheezing and chest tightness.
Bronchodilators
A class of medications that cause the smooth muscle in the lungs to relax.
SABA (Short-Acting Beta-2 Agonist)
A fast-acting bronchodilator (such as albuterol) that opens up the bronchioles.
SAMA (Short-Acting Muscarinic Antagonist)
An inhaled anticholinergic medication (such as ipratropium) that acts on the parasympathetic nervous system to prevent bronchioles from shutting.
LABA (Long-Acting Beta-2 Agonist)
A long-acting bronchodilator (such as formoterol) that stimulates smooth muscle relaxation to keep the airways open over time.
LAMA (Long-Acting Muscarinic Antagonist)
A long-acting bronchodilator that blocks bronchoconstriction and excessive mucus production.
Inhaled Corticosteroids
Maintenance therapy inhaled over time to decrease and prevent lung inflammation; per GINA guidelines, they must be combined with bronchodilators.
Eosinophils
A type of white blood cell identified on a complete blood count (CBC) that increases during allergic reactions and asthma exacerbations.
Signs of Impending Death in Asthma
Critical physical and laboratory signs of respiratory failure consisting of a silent chest and a PCO2>70mmHg.
Chronic Obstructive Pulmonary Disease (COPD)
A progressive disease characterized by chronic inflammation and airflow obstruction resulting from inhalation of toxic substances or occupational pollutants.
Alpha-1 Antitrypsin Deficiency
A genetic condition characterized by the inability to produce anti-elastase, leading to the unchecked enzymatic breakdown of alveoli.
Elastase
An enzyme that protects against infection but breaks down lung tissue, cells, and proteins when left unchecked by anti-elastase.
Chronic Bronchitis
A component of COPD characterized by long-term inflammation of the bronchiole tubes where excess mucus plugs the airways.
Emphysema
A component of COPD characterized by the progressive breakdown and destruction of the alveoli.
Cor Pulmonale
Right-sided heart failure resulting from chronic hypoxemia-induced pulmonary vessel constriction and pulmonary hypertension.
FEV1/FVC Ratio
A diagnostic spirometric ratio used to evaluate lung obstruction; a value under 70% indicates an obstructive pattern.
Supplemental Oxygen Target in COPD
The recommended arterial oxygen saturation range of 88−92%; exceeding this range can trigger decompensation.